A bit on the side. Adjunctive treatments for type 1 diabetes
This CME session explores adjunctive therapies for type 1 diabetes, focusing on GLP-1 Receptor Agonists and beta-cell metabolic fitness.
- The description claims that GLP-1 RAs can reduce total daily insulin doses and body weight without increasing the risk of severe hypoglycaemia.
AI Readiness
Good foundation, but some important product data is still missing.
72%